Upregulation of microRNA-146a was not accompanied by downregulation of pro-inflammatory markers in diabetic kidney

Molecular Biology Reports

Volumn 40, Issue 11, 2013, Pages 6477-6483

  Alipour, Mohammad Reza ^a,b   Khamaneh, Amir Mahdi ^c   Yousefzadeh, Nasibeh ^a,c   Mohammad Nejad, Daryoush ^b   Soufi, Farhad Ghadiri ^d  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d HORMOZGAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes; MicroRNAs; Nephropathy; NF jB

Indexed keywords

CREATININE; INSULIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; MICRORNA 146A; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DOWN REGULATION; ENDOTHELIUM CELL; INSULIN BLOOD LEVEL; MESANGIUM CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; UPREGULATION; UREA BLOOD LEVEL;

ANIMALS; BIOLOGICAL MARKERS; CYTOKINES; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; INFLAMMATION MEDIATORS; KIDNEY; KIDNEY GLOMERULUS; MALE; MICRORNAS; NF-KAPPA B; RATS;

EID: 84892709897     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-013-2763-4     Document Type: Article

References (27)

1. Luis-Rodríguez D, Martínez-Castelao A, Górriz JL, De-Alvaro F, Navarro-González JF (2012) Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy. World J Diabetes 15:7-18. doi:10.4239/wjd.v3.i1.7
2. Zhou X, Wang B, Zhu L, Hao S (2012) A novel improved therapy strategy for diabetic nephropathy: targeting AGEs. Organogene-sis 1:18-21. doi:10.4161/org.19332
3. Palsamy P, Subramanian S (2010) Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic b-cell dysfunction in strep-tozotocin-nicotinamide-induced diabetic rats. J Cell Physiol 224:423-432. doi:10.1002/jcp.22138
4. Palsamy P, Subramanian S (2011) Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling. Biochim Biophys Acta 1812:719-731. doi:10.1016/j.bbadis. 2011.03.008
5. Sanz AB, Sanchez-Niño MD, Ramos AM, Moreno JA, Santam-aria B, Ruiz-Ortega M, Egido J, Ortiz A (2010) NF-kappaB in renal inflammation. J Am Soc Nephrol 21:1254-1262. doi:10. 1681/ASN.2010020218
6. Patel S, Santani D (2009) Role of NF-kappa B in the pathogenesis of diabetes and its associated complications. Pharmacol Rep 61:595-603
7. Ma X, Becker Buscaglia LE, Barker JR, Li Y (2011) MicroRNAs in NF-kappaB signaling. J Mol Cell Biol 3:159-166. doi:10.1093/jmcb/mjr007
8. Rusca N, Monticelli S (2011) MiR-146a in immunity and disease. Mol Biol Int 2011:437301. doi:10.4061/2011/437301
9. Balasubramanyam M, Aravind S, Gokulakrishnan K, Prabu P, Sathishkumar C, Ranjani H, Mohan V (2011) Impaired miR-146a expression links subclinical inflammation and insulin resistance in type 2 diabetes. Mol Cell Biochem 351:197-205. doi:10.1007/s11010-011-0727-3
10. Feng B, Chen S, McArthur K, Wu Y, Sen S, Ding Q, Feldman RD, Chakrabarti S (2011) miR-146a-Mediated extracellular matrix protein production in chronic diabetes complications. Diabetes 60:2975-2984. doi:10.2337/db11-0478
11. Wang G, Kwan BC, Lai FM, Chow KM, Li PK, Szeto CC (2011) Elevated levels of miR-146a and miR-155 in kidney biopsy and urine from patients with IgA nephropathy. Dis Markers 1:171-179. doi:10.3233/DMA-2011-0766
12. Ichii O, Otsuka S, Sasaki N, Namiki Y, Hashimoto Y, Kon Y (2012) Altered expression of microRNA miR-146a correlates with the development of chronic renal inflammation. Kidney Int 81:280-292. doi:10.1038/ki.2011.345
13. Yar AS, Menevse S, Alp E, Helvacioglu F, Take G (2010) The effects of resveratrol on cyclooxygenase-1 and cyclooxygenase-2 mRNA and protein levels in diabetic rat kidneys. Mol Biol Rep 37:2323-2331. doi:10.1007/s11033-009-9737-6
14. Arora MK, Reddy K, Balakumar P (2010) The low dose combination of fenofibrate and rosiglitazone halts the progression of diabetes-induced experimental nephropathy. Eur J Pharmacol 636:137-144. doi:10.1016/j.ejphar. 2010.03.002
15. Tikoo K, Singh K, Kabra D, Sharma V, Gaikwad A (2008) Change in histone H3 phosphorylation, MAP kinase p38, SIR 2 and p53 expression by resveratrol in preventing streptozotocin induced type I diabetic nephropathy. Free Radic Res 42:397-404. doi:10.1080/10715760801998646
16. LässerC, Eldh M, Lötvall J (2012) Isolation and characterization of RNA-containing exosomes. J Vis Exp 59:e3037. doi:10.3791/3037
17. Biyashev D, Veliceasa D, Topczewski J, Topczewska JM, Miz-girev I, Vinokour E, Reddi AL, Licht JD, Revskoy SY, Volpert OV (2012) miR-27b controls venous specification and tip cell fate. Blood 119:2679-2687. doi:10.1182/blood-2011-07-370635
18. Fink T, Lund P, Pilgaard L, Rasmussen JG, Duroux M, Zachar V (2008) Instability of standard PCR reference genes in adipose-derived stem cells during propagation, differentiation and hyp-oxic exposure. BMC Mol Biol 9:98. doi:10.1186/1471-2199-9-98
19. Peltier HJ, Latham GJ (2008) Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 14:844-852. doi:10.1261/rna.939908
20. Wu CC, Sytwu HK, Lin YF (2012) Cytokines in diabetic nephropathy. Adv Clin Chem 56:55-74. doi:10.1016/B978-0-12-394317-0.00014-5
21. Leung KK, Leung PS (2008) Effects of hyperglycemia on angiotensin II receptor type 1 expression and insulin secretion in an INS-1E pancreatic beta-cell line. JOP 9:290-299
22. Willemsen JM, Westerink JW, Dallinga-Thie GM, van Zonne-veld AJ, Gaillard CA, Rabelink TJ, de Koning EJ (2007) Angiotensin II type 1 receptor blockade improves hyperglycemia-induced endothelial dysfunction and reduces proinflammatory cytokine release from leukocytes. J Cardiovasc Pharmacol 49:6-12. doi:10.1097/FJC.0b013e31802b31a7
23. Thomson SC, Deng A, Bao D, Satriano J, Blantz RC, Vallon V (2001) Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes. J Clin Invest 107:217-224. doi:10.1172/JCI10963
24. Lovis P, Roggli E, Laybutt DR, Gattesco S, Yang JY, Widmann C, Abderrahmani A, Regazzi R (2008) Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction. Diabetes 57:2728-2736. doi:10.2337/db07-1252
25. Zilahi E, Tarr T, Papp G, Griger Z, Sipka S, Zeher M (2012) Increased microRNA-146a/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sjögren's syndrome. Immunol Lett 141:165-168. doi:10. 1016/j.imlet.2011.09.006
26. Liu Z, Xiao B, Tang B, Li B, Li N, Zhu E, Guo G, Gu J, Zhuang Y, Liu X, Ding H, Zhao X, Guo H, Mao X, Zou Q (2010) Up-regulated microRNA-146a negatively modulate Helicobacter pylori-induced inflammatory response in human gastric epithelial cells. Microbes Infect 12:854-863. doi:10.1016/j.micinf.2010.06. 002
27. Roggli E, Britan A, Gattesco S, Lin-Marq N, Abderrahmani A, Meda P, Regazzi R (2010) Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells. Diabetes 59:978-986. doi:10.2337/db09-0881